Revenue growth in healthcare comes down to execution: a repeatable enterprise sales model, disciplined pipeline math, and pricing that holds. The strategies that actually move the number.

Somewhere between $5M and $25M ARR, every board asks the CRO question. Hire full-time, go fractional, or wait? A practical framework for healthcare founders.

PE investors are not asking whether you have good salespeople. They are asking whether your revenue system produces a predictable outcome at a known cost. What they look for.

Rising acquisition costs, slipping deals, pipeline that looks fine on paper: the early warning signs that your revenue architecture has stopped scaling, and what to do about each.

Growth slowed, and four executives give four different answers. The four questions that separate real revenue leadership from a soft-quarter explanation.